As per the WHO statistics, the global prevalence of diabetes, increased to 8.5% in adults over the age of 18 in the year 2014 from 4.7% in the year 1980. This rising prevalence of chronic diseases has led to an increase in the demands for improved treatments and diagnostic services. For the treatment of these types of diseases, various novel ways to administer drugs have been developed such as needle-free injectors, autoinjectors, pen injectors, and pre-filled syringes. According to the latest market intelligence report by BIS Research titled, ‘Global Injectable Drug Delivery Market- Analysis and Forecast (2018-2025),’ the market was estimated at $16.73 billion in 2016. The market for drug injectable is anticipated to grow over $37.47 billion by the year 2025. This significant growth is majorly attributed to the increase in the chronic diseases along with the rise in the geriatric population.